Literature DB >> 23136130

Aptamer-functionalized, ultra-small, monodisperse silica nanoconjugates for targeted dual-modal imaging of lymph nodes with metastatic tumors.

Li Tang1, Xujuan Yang, Lawrence W Dobrucki, Isthier Chaudhury, Qian Yin, Catherine Yao, Stéphane Lezmi, William G Helferich, Timothy M Fan, Jianjun Cheng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23136130      PMCID： PMC4486261          DOI： 10.1002/anie.201205271

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  45 in total

1.  Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes.

Authors:  Xinglu Huang; Fan Zhang; Seulki Lee; Magdalena Swierczewska; Dale O Kiesewetter; Lixin Lang; Guofeng Zhang; Lei Zhu; Haokao Gao; Hak Soo Choi; Gang Niu; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2012-03-16       Impact factor: 12.479

2.  LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases.

Authors:  Carola Leuschner; Challa S S R Kumar; William Hansel; Wole Soboyejo; Jikou Zhou; Josef Hormes
Journal:  Breast Cancer Res Treat       Date:  2006-06-03       Impact factor: 4.872

Review 3.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

4.  Imaging tumor-induced sentinel lymph node lymphangiogenesis with LyP-1 peptide.

Authors:  Fan Zhang; Gang Niu; Xin Lin; Orit Jacobson; Ying Ma; Henry S Eden; Yulong He; Guangming Lu; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2011-07-19       Impact factor: 3.520

5.  In vivo quantitative evaluation of the transport kinetics of gold nanocages in a lymphatic system by noninvasive photoacoustic tomography.

Authors:  Xin Cai; Weiyang Li; Chul-Hong Kim; Yuchen Yuan; Lihong V Wang; Younan Xia
Journal:  ACS Nano       Date:  2011-11-15       Impact factor: 15.881

6.  Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model.

Authors:  Huan Meng; Min Xue; Tian Xia; Zhaoxia Ji; Derrick Y Tarn; Jeffrey I Zink; Andre E Nel
Journal:  ACS Nano       Date:  2011-04-27       Impact factor: 15.881

7.  In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles.

Authors:  Rajiv Kumar; Indrajit Roy; Tymish Y Ohulchanskky; Lisa A Vathy; Earl J Bergey; Munawwar Sajjad; Paras N Prasad
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

8.  The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.

Authors:  Sridharan Soundararajan; Weiwei Chen; Eleanor K Spicer; Nigel Courtenay-Luck; Daniel J Fernandes
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

Review 9.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

Review 10.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694
View more
  34 in total

1.  Nonporous Silica Nanoparticles for Nanomedicine Application.

Authors:  Li Tang; Jianjun Cheng
Journal:  Nano Today       Date:  2013-06       Impact factor: 20.722

2.  Selective in vivo metabolic cell-labeling-mediated cancer targeting.

Authors:  Hua Wang; Ruibo Wang; Kaimin Cai; Hua He; Yang Liu; Jonathan Yen; Zhiyu Wang; Ming Xu; Yiwen Sun; Xin Zhou; Qian Yin; Li Tang; Iwona T Dobrucki; Lawrence W Dobrucki; Eric J Chaney; Stephen A Boppart; Timothy M Fan; Stéphane Lezmi; Xuesi Chen; Lichen Yin; Jianjun Cheng
Journal:  Nat Chem Biol       Date:  2017-02-13       Impact factor: 15.040

3.  Aptamer photoregulation in vivo.

Authors:  Lele Li; Rong Tong; Hunghao Chu; Weiping Wang; Robert Langer; Daniel S Kohane
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

4.  DNA Aptamer Technology for Personalized Medicine.

Authors:  Hang Xing; Kevin Hwang; Ji Li; Seyed-Fakhreddin Torabi; Yi Lu
Journal:  Curr Opin Chem Eng       Date:  2014-05-01       Impact factor: 5.163

5.  Investigating the optimal size of anticancer nanomedicine.

Authors:  Li Tang; Xujuan Yang; Qian Yin; Kaimin Cai; Hua Wang; Isthier Chaudhury; Catherine Yao; Qin Zhou; Mincheol Kwon; James A Hartman; Iwona T Dobrucki; Lawrence W Dobrucki; Luke B Borst; Stéphane Lezmi; William G Helferich; Andrew L Ferguson; Timothy M Fan; Jianjun Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-14       Impact factor: 11.205

Review 6.  Nanoparticles for imaging and treatment of metastatic breast cancer.

Authors:  Qingxin Mu; Hui Wang; Miqin Zhang
Journal:  Expert Opin Drug Deliv       Date:  2016-07-19       Impact factor: 6.648

Review 7.  Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.

Authors:  Shreya Goel; Christopher G England; Feng Chen; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2016-08-09       Impact factor: 15.470

Review 8.  Aptamers: versatile molecular recognition probes for cancer detection.

Authors:  Hongguang Sun; Weihong Tan; Youli Zu
Journal:  Analyst       Date:  2016-01-21       Impact factor: 4.616

9.  Pretargeted Positron Emission Tomography Imaging That Employs Supramolecular Nanoparticles with in Vivo Bioorthogonal Chemistry.

Authors:  Shuang Hou; Jin-Sil Choi; Mitch Andre Garcia; Yan Xing; Kuan-Ju Chen; Yi-Ming Chen; Ziyue K Jiang; Tracy Ro; Lily Wu; David B Stout; James S Tomlinson; Hao Wang; Kai Chen; Hsian-Rong Tseng; Wei-Yu Lin
Journal:  ACS Nano       Date:  2016-01-12       Impact factor: 15.881

10.  Photoswitchable nanoparticles for in vivo cancer chemotherapy.

Authors:  Rong Tong; Homer H Chiang; Daniel S Kohane
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.